These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

A federal judge has vacated five of seven complaints against UnitedHealth Group—yet is allowing the AI-implicated suit to advance. 

Two in five practicing physicians are equal parts enthused over and worried about AI in healthcare. That’s the same ratio the American Medical Association turned up the last time it conducted its Physician Sentiment Survey.

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

End-of-life decisions are often anything but easy. AI might be able to help. 

An international cluster of 117 researchers from 50 countries has arrived at a consensus on six principles that, in the team’s considered view, ought to guide the use of AI across healthcare worldwide. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated?